Ginsenoside Rg1 alleviates MAFLD by inhibiting oxidative stress and ferroptosis via the Nrf2/GPX4 pathway
Year: 2026
Type: article
Abstract: Metabolic dysfunction-associated fatty liver disease (MAFLD) imposes a significant global health burden, and safe and effective treatments are still lacking. Ginsenoside Rg1 (Rg1), a key bioactive compound extracted from ginseng, can effectively alleviate liver injury associated with MAFLD, but the specific molecular mechanism remains unclear. This study aims to investigate the therapeutic effects of Rg1 on MAFLD and elucidate its underlying mechanisms. A mouse model was established using the methionine-choline-deficient (MCD) diet, and Rg1 was given intragastrically for 4 consecutive weeks. The effects of Rg1 on MAFLD were investigated in vitro by cultivating HepG2 cells with free fatty acids (FFA). We used commercial assay kits, histopathological staining, transmission electron microscopy (TEM), immunofluorescence (IF), polymerase chain reaction (PCR), and Western blotting (WB) to assess parameters related to inflammation, oxidative stress, and ferroptosis in liver tissue and HepG2 cells. Molecular docking, cellular thermal shift assay (CETSA), and the Nrf2 inhibitor (ML385) were used to validate the potential mechanisms underlying the hepatoprotective effects of Rg1. Rg1 treatment dramatically reduced hepatic Fe 2+ , oxidative stress, and inflammatory factor levels. In vitro experiments revealed that Rg1 reduced iron, MDA, and ROS levels, while upregulating SLC7A11 and GPX4 to inhibit oxidative stress and ferroptosis. These results suggest that Rg1 exerts antioxidant and antiferroptotic effects by activating the Nrf2/GPX4 signaling pathway. Rg1 is a natural bioactive compound with potential therapeutic applications for MAFLD; it attenuates MCD/FFA-induced hepatic injury by inhibiting oxidative stress and ferroptosis, at least partly through activation of the Nrf2/GPX4 pathway.
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,190
OpenAlex ID: W7165560071
